“The Week”: Central bankers in focus

• 

  François Bloch
  Experte

Switzerland

The Novartis-shares (NOVN SW) have emerged impressively from the “valley of tears” at the turn of 2024/2025, gaining 12.16% since the beginning of the year. The operating result (EBIT) could rise to CHF 22.573 billion by 2027. At the same time, the EBIT margin should also increase to 39.17%. This expected jump in the margin explains the growing investor interest.
Trading strategy: Reload.

The titles of Avolta (AVOL SW) have firmly established themselves on the Swiss stock exchange in 2025 and have gained a remarkable 27.30% since the beginning of the year. EBIT could climb to CHF 1.166 billion by 2027 – an important step back to its former strength.
Trading strategy: Reload.

Particularly exciting at the moment are the shares of Zurich Airport (FHZN SW), which are still trading under the radar of large financial investors – but probably not for much longer. EBIT could rise to CHF 486.2 million by 2027. Despite the slightly higher valuation compared to Vienna Airport, it is worth investing here.
Trading strategy: Reload.

After a prolonged period of weakness, the situation at Lonza (LONN SW) is brightening up again. The CHF 39.16 billion stock could increase its EBIT to CHF 2.086 billion by 2027 – a clear exclamation mark after a lean period.
Trading strategy: Reload.

The shares of Sandoz (SDZ SW). The book value per share could rise to CHF 25.12 by 2027. The development of the EBT margin could be even stronger, soaring to 16.38% in the same period. The dividend per share is also likely to increase. Trading strategy: Reload.

The titles of Schindler Holding (SCHP SW) deserve increased attention. The book value per share could rise to CHF 55.80 by 2027. In my view, the reinvestment of annual dividends, which could rise to CHF 7,578, is important.
Trading strategy: Reload.

Europe

The securities of Commerzbank (CBK GY) are currently developing into a particularly hot item, as they have really fired up on the Frankfurt Stock Exchange. The book value per share could rise to EUR 31.27 by 2027. More impressive for me is the development of the dividend per share, which should climb to EUR 1,521 in the same period.
Trading strategy: Reload.

You should consider the still moderate entry level for the shares of Airbus (AIR FP). According to my models, EBIT could rise to EUR 9.857 billion by 2027 – a strong figure for the EUR 148 billion group. According to my models, the EBIT margin should exceed the 10% mark for the first time in 2027. In my view, it is important to reinvest the dividends in new shares. Trading strategy: reload.

The shares of Telecom Italia (TIT). A dividend yield of 3.67% is expected for 2026. EBIT could rise to EUR 1.781 billion by 2027, with a forecast EBIT margin of 12.24% in 2027.
Trading strategy: Reload.

The business strategy of Bank of Ireland (BIRG IE) is exciting. The book value per share could improve to EUR 12.65 by 2027. In addition, the dividend yield could exceed 5.5% in 2027 for the first time in the company’s history.
Trading strategy: Reload.

Also at Prosus N.V. (PRX NA) finally seems to have land in sight. EBIT could rise to EUR 1.142 bn by 2028. The decisive factor for me is the annual reinvestment of dividends, which could rise to EUR 0.2407 per share.
Trading strategy: Reload.

My models for the Spanish Iberdrola (IBE SM) are very positive. EBIT could grow to EUR 11.901 bn by 2027 – a strong increase. With an expected EBIT margin of 23.73% in 2027, the utility underlines its strength.
Trading strategy: Reload.

An excellent start to 2025 for AXA (CS FP). EBIT could rise to EUR 12.021 billion by 2027. At the same time, the dividend per share could increase to EUR 2.66.
Trading strategy: Reload.

The shares of the French construction and concession specialist Vinci (DG FP). EBIT could rise to EUR 10.369 bn by 2027. According to my models, the dividend development to EUR 5.83 (2027) should be pleasing. Here, too, the dividend should be reinvested.
Trading strategy: Reload.

The Spanish Aena (AENA IM) IS SURPRISINGLY STRONG. EBIT could rise to EUR 3.201 billion in 2027. At the same time, the book value per share should improve to EUR 6.74. The same applies here: reinvest the dividends.
Trading strategy: Reload.

The French Eiffage S.A. (FGR FP) is currently in sixth gear: +48.67% since the beginning of the year. EBIT could increase to EUR 2.787 billion by 2027 – a very strong performance for this sector.
Trading strategy: Reload.

The up-and-comers also include the Spanish BBVA (BBVA SM). The book value per share could improve to EUR 11.85 by 2027. There should also be a clear increase in the dividend: to EUR 0.9181 per share.
Trading strategy: Reload.

USA

For growth-oriented investors, there is hardly any way around Beone Medicines (ONC, US). The group, which specializes in the development of cancer drugs, could increase its operating result (EBIT) to USD 1.18 billion by 2027. The only thing that is in the doldrums until at least 2027 is the dividend; no distributions are planned.
Trading strategy: New.

Also exciting is Incyte (INCY, US). The US company impresses with its enormous clout. EBIT could improve to USD 2.125 billion by 2027. At the same time, the EBIT margin could reach 36.56% in 2027 – a figure that should attract entirely new groups of buyers to the stock.
Trading strategy: Reload.

An entry could be worthwhile with T-Mobile US (TMUS, US) could be worthwhile. EBIT should rise to USD 3.835 billion by 2027. At the same time, the EBITDA margin could reach 41.22% in 2027 – a clear signal of the strength of this “hidden champion”.
Trading strategy: Reload.

The Swedish music streaming specialist Spotify Technology (SPOT, US) has shown impressive consistency over the years. EBIT could improve to USD 3.385 billion by 2027. At the same time, the book value per share could rise to USD 60.28 – an almost unbelievable development.
Trading strategy: Reload.

Yours sincerely,
François Bloch

____

Disclaimer
payoff Media AG and François Bloch receive neither payments nor commissions from the products mentioned.